{{Rsnum
|rsid=1056890
|Gene=PSD
|Chromosome=10
|position=104162770
|Orientation=minus
|GMAF=0.2622
|Gene_s=NFKB2,PSD
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=137
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 39.8 | 47.8 | 12.4
| HCB | 65.0 | 33.6 | 1.5
| JPT | 58.4 | 35.4 | 6.2
| YRI | 81.0 | 18.4 | 0.7
| ASW | 66.7 | 29.8 | 3.5
| CHB | 65.0 | 33.6 | 1.5
| CHD | 70.6 | 27.5 | 1.8
| GIH | 25.7 | 44.6 | 29.7
| LWK | 82.7 | 16.4 | 0.9
| MEX | 22.4 | 58.6 | 19.0
| MKK | 57.4 | 40.6 | 1.9
| TSI | 41.6 | 51.5 | 6.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=23153769
|Title=Impact of NF-κB gene polymorphism on allograft outcome in Hispanic renal transplant recipients
}}

{{PMID Auto
|PMID=21228035
|Title=Polymorphisms of nuclear factor-kappaB family genes are associated with development of multiple myeloma and treatment outcome in patients receiving bortezomib-based regimens.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}